                         SEQUENCE LISTING

<110>  DIGNIFY THERAPEUTICS, Inc.
 
<120>  COMPOSITIONS AND METHODS FOR INDUCING URINARY VOIDING AND 
       DEFECATION

<130>  336/4 PCT

<140>  PCT/US2014/048953
<141>  2014-07-30

<150>  US 61/860995
<151>  2013-08-01

<160>  7     

<170>  PatentIn version 3.5

<210>  1
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Leu at position 6 is methylated at the nitrogen

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  X at position 7 is norleucine

<400>  1

Asp Lys Phe Val Gly Leu Xaa 
1               5           


<210>  2
<211>  10
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Met at position 10 has a NH2 group at the carboxyl terminus

<400>  2

His Lys Thr Asp Ser Phe Val Gly Leu Met 
1               5                   10  


<210>  3
<211>  10
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Met at position 10 has a NH2 group at the carboxyl terminus

<400>  3

Asp Met His Asp Phe Phe Val Gly Leu Met 
1               5                   10  


<210>  4
<211>  11
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Met at position 11 has a NH2 group at the carboxyl terminus

<400>  4

Arg Pro Lys Pro Gln Gln Phe Phe Gly Leu Met 
1               5                   10      


<210>  5
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Met at position 7 has a NH2 group at the carboxyl terminus

<400>  5

Asp Ser Phe Val Gly Leu Met 
1               5           


<210>  6
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  X at at position 5 is a beta alanine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Met at at position 7 has a NH2 group at the carboxyl terminus

<400>  6

Asp Ser Phe Val Xaa Leu Met 
1               5           


<210>  7
<211>  5
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  X at position 2 is eitherTyr, Phe, Val, or Ile

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Met at position 5 has a NH2 group at the carboxyl terminus

<400>  7

Phe Xaa Gly Leu Met 
1               5   


